References
- Young RA, Gonzalez JP, Sorkin EM. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1989; 37: 8-41.
- Kafetzis DA, Blanc F. Efficacy and safety of roxithromycin in treating paediatric patients. A European multicentre study. J Antimicrob Chemother 1987; 20, Suppl. B: 171-177.
- Stamboulian D, Fernandez MacLoughlin GJ, , Lanoël JL, Sarachian B. Clinical evaluation of roxithromycin in 101 children. Br J Clin Pract Suppl 1987; 55: 115-116.
- Bazet MC, Blanc F, Chumdermpadetsuk, et al. Roxithromycin in the treatment of paediatric infections. Br J Clin Pract Suppl 1987; 55: 117-118.
- Casellas JM, Rodriguez JA, Fernandez MacLoughlin GJ, Lanoel JL. Efficacy of roxithromycin in the treatment of acute otitis media in infants. Br J Clin Pract Suppl 1987; 55: 113-114.
- Biaxin Formulary Monograph, Abbott Laboratories 1992.
- Kirst HA, Sides GD. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother 1989; 23: 1419-1422.
- O’Sullivan N, Wise R. Macrolide, lincosamide, and streptogramin antibiotics. Curr Opinion Infect Dis 1990; 3: 743-750.
- Stahlmann R, Lode H. Clarithromycin – ein neues Macrolidantibiotikum. Arzneimittelther 1991; 9: 225-228.
- Dirithromycin, Clinical Investigation Brochure, Eli Lilly Company 1988.
- Akita H, Niwa I, Yamashita R, Sunakawa K, Yokota TR. Bacteriological response to rokitamycin in pediatric patients with mycoplasmal infection (a study with a DNA probe technique): Proceeding 17th Internat. Congress of Chemotherapy, Berlin/Germany, 1991.
- Giovannini M, Riva E, Zuccotti G. Pharmacokinetic and clinical trial of rokitamycin in children. Proceedings 17th Internat. Congress of Chemotherapy, Berlin/Germany, 1991.
- Caramia G, Ruffini E, de Bellis OM, Nobilini A, Bartolucci MA. Efficacy and safety of rokitamycin vs amoxicillin in the treatment of acute otitis media (AOM) in pediatric patients. Proceedings 17th Internat. Congress of Chemotherapy, Berlin/Germany, 1991.
- Motohiro T, Fujii R, Sasaki H, Koga T, Sakata Y, Yamashita F. A comparative study of the efficacy of rokitamycin vs those of erythromycin and fosfomycin against pediatric Campylobacter enteritis. Proceedings 17th Internat. Congresso of Chemotherapy, Berlin/Germany 1991.
- Kaku M, Suyama N, Tornita H, Koga H, Kohno S. Izumikawa K, Hara K. Comparison of bacteriological response (eradication of Mycoplasma pneumoniae) of rokitamycin with erythromycin and midecamycin acetate in the adult M. pneumoniae infection. Proceedings 17th Internat. Congress of Chemotherapy, Berlin/Germany, 1991.
- Pestalozza G. Azithromycin in upper respiratory tract infections. Abstract No 132. 5th European Congress of Clin Microbiol and Infectious Diseases.
- Archer G, Auger P, Doem G et al. RP 59500 is highly active against current isolates of North American Staphylococci. Abstract 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago 111 1991.
- Bazet MC, Blanc F, Chumdermapdadetsuk, et al. Roxithromycin in the treatment of paediatric infections. Br J Clin Pract Suppl 1987; 55: 117-118.
- Georgopoulos, Breyer S, Georgopoulos M, Feistauer S, Janata O, Graninger W. Comparative activity of RP 59500 against erythromycin resistant strains of staphylococci. Abstract 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill 1991.